Table 2.

The importance weights of the region/task pairs that passed permutation significance testing (p = 0.05). Here, positive signs indicate a positive association with remission. These results were calculated by averaging the predictor importance weights assigned by the classification across all ten folds of cross-validation and over all thirty trials.

	Baseline	1st dose change
Emotional reactivity	Left middle frontal gyrus: −0.29	Left/right inferior frontal gyrus, pars orbitalis: +0.40/+0.31
	Left lateral orbitofrontal cortex: −0.38	Left middle frontal gyrus, orbital part: +0.43
	Right hippocampus: −0.58	Left rectus: +0.61
	Right parahippocampus −0.45	Left lingual: +0.19
	Right fusiform: −0.34	Right superior occipital gyrus: −0.32
	Left caudate: −0.37	Right middle occipital gyrus: −0.28
	Right inferior temporal gyrus: −0.43	Right angular gyrus: −0.37
Emotional regulation	Left superior frontal gyrus, orbital part: +0.37	Left middle cingulate area: +0.19
	Left middle frontal gyrus, orbital part: +0.30	Left cuneus (increased): +0.27
	Left middle frontal gyrus: +0.27	Left/right precuneus: +0.23/+0.18
	Left/Right middle cingulate area: −0.25/−0.25	Right paracentral lobule: +0.29
	Right paracentral lobule: −0.31	Right caudate: −0.31
		Left thalamus: −0.26
Resting state centrality	Left inferior frontal gyrus, pars opercularis: +0.46	Left superior temporal gyrus: −0.54
	Right parahippocampus: −0.46
	Right fusiform: −0.36
	Left caudate: −0.45